April 6, 2020
ObsEva sets up interim CFO
Switzerland-based ObsEva SA has nominated Fabien de Ladonchamps, Vice President Corporate Affairs & Finance, as interim Chief Financial Officer and member of the Executive Committee.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 3, 2020
Novartis, Incyte test using Jakavi for respiratory problems in COVID-19 patients
Novartis said on Thursday it aims to start a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for the treatment of a type of severe immune overreaction called cytokine storm that can lead to life-threatening respiratory complications in patients with COVID-19.
April 3, 2020
Dupixent phase 3 testing has good result in atopic dermatitis
Sanofi and Regeneron’s phase 3 clinical trial results announced Friday show Dupixent (dupilumab) combined with standard-of-care topical corticosteroids (TCS) in children aged 6-11 years with uncontrolled severe atopic dermatitis significantly improved disease signs, symptoms and health-related quality of life.
April 2, 2020
Hygiena launches all-in-one Listeria, L. monocytogenes detection method
Hygiena, a global leader in rapid microbial detection, monitoring, and identification technology, introduced the InSite L. mono Glo Environmental Surface Screening Test. InSite L. mono Glo Environmental Surface Screening Test. InSite L. monoGlo is an easy-to-use, self-contained, environmental sampling and screening test for Listeria species and Listeria monocytogenes (L. mono).
April 2, 2020
– PBOA: Pharma industry, supply chain have positive outlook
The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that many of its member companies are actively involved in helping their clients develop and produce treatments, vaccines, and diagnostics for COVID-19. PBOA’s members provide a wide array of services throughout the bio/pharma sector.
April 2, 2020
PCR Biosystems makes 4M of COVID-19 test reagents daily
PCR Biosystems, the UK-based PCR experts, PCR Biosystems has the capacity to manufacture enough reagent daily for 4 million reactions – which is sufficient for millions of diagnostic tests
April 2, 2020
Austrian Aperion OKd to phase2 test APN01 to treat COVID-19 in 3 EU countries
Apeiron Biologics AG has received regulatory approvals in Austria, Germany and Denmark to kickoff a Phase II clinical trial of APN01 to treat COVID-19.
April 1, 2020
Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
Three leading biopharmaceutical companies have announced programs enabling employees with medical and laboratory expertise to volunteer their services to local…
March 31, 2020
Ritedose selects ChargePoint Technology’s transfer solution for biomanufacturing project
The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered…
March 31, 2020
Lonza launches medium for gene therapy applications AAV production
Swiss-based Lonza has launched the TheraPEAK SfAAV Medium, the first chemically defined, non-animal origin medium designed specifically for the production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells for gene therapy applications.